HAX1 regulates E3 ubiquitin ligase activity of cIAPs by promoting their dimerization

Oncotarget

Volumn 5, Issue 20, 2014, Pages 10084-10099

  Choi, Jin Sun ^a,e   Park, Byoung Chul ^a   Chi, Seung Wook ^a   Bae, Kwang Hee ^a   Kim, Sunhong ^a,g   Cho, Sayeon ^b   Son, Woo Chan ^c,d   Myung, Pyung Keun ^e   Kim, Jeong Hoon ^a,f   Park, Sung Goo ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chung Ang University   (South Korea)

^c Asan Medical Center   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

^e Chungnam National University   (South Korea)

^f Department of Functional Genomics ^*  (South Korea)

^g University of Science and Technology (UST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HS 1 ASSOCIATED PROTEIN X 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; NUCLEAR FACTOR KAPPA B INDUCING KINASE; PROTEASOME; PROTEIN; PROTEIN KINASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; BIRC3 PROTEIN, HUMAN; HAX1 PROTEIN, HUMAN; NF-KAPPA B KINASE; PROTEIN SERINE THREONINE KINASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; UBIQUITIN PROTEIN LIGASE;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME REGULATION; ENZYME STABILITY; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RING FINGER MOTIF; UBIQUITINATION; APOPTOSIS; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN MULTIMERIZATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; CELL LINE, TUMOR; HEK293 CELLS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; NF-KAPPA B; PROTEIN MULTIMERIZATION; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TRANSFECTION; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84930469021     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2459     Document Type: Article

References (53)

1. Suzuki Y, Demoliere C, Kitamura D, Takeshita H, Deuschle U and Watanabe T. HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases. Journal of immunology. 1997; 158(6):2736-2744.
2. Jeyaraju DV, Cisbani G, De Brito OM, Koonin EV and Pellegrini L. Hax1 lacks BH modules and is peripherally associated to heavy membranes: implications for Omi/HtrA2 and PARL activity in the regulation of mitochondrial stress and apoptosis. Cell death and differentiation. 2009; 16(12):1622-1629.
3. Han Y, Chen YS, Liu Z, Bodyak N, Rigor D, Bisping E, Pu WT and Kang PM. Overexpression of HAX-1 protects cardiac myocytes from apoptosis through caspase-9 inhibition. Circulation research. 2006; 99(4):415-423.
4. Vafiadaki E, Arvanitis DA, Pagakis SN, Papalouka V, Sanoudou D, Kontrogianni-Konstantopoulos A and Kranias EG. The anti-apoptotic protein HAX-1 interacts with SERCA2 and regulates its protein levels to promote cell survival. Molecular biology of the cell. 2009; 20(1): 306-318.
5. Vafiadaki E, Sanoudou D, Arvanitis DA, Catino DH, Kranias EG and Kontrogianni-Konstantopoulos A. Phospholamban interacts with HAX-1, a mitochondrial protein with anti-apoptotic function. Journal of molecular biology. 2007; 367(1):65-79.
6. Chao JR, Parganas E, Boyd K, Hong CY, Opferman JT and Ihle JN. Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons. Nature. 2008; 452(7183):98-102.
7. Trebinska A, Rembiszewska A, Ciosek K, Ptaszynski K, Rowinski S, Kupryjanczyk J, Siedlecki JA and Grzybowska EA. HAX-1 overexpression, splicing and cellular localization in tumors. BMC cancer. 2010; 10:76.
8. Smith BN, Ancliff PJ, Pizzey A, Khwaja A, Linch DC and Gale RE. Homozygous HAX1 mutations in severe congenital neutropenia patients with sporadic disease: a novel mutation in two unrelated British kindreds. British journal of haematology. 2009; 144(5):762-770.
9. Klein C, Grudzien M, Appaswamy G, Germeshausen M, Sandrock I, Schaffer AA, Rathinam C, Boztug K, Schwinzer B, Rezaei N, Bohn G, Melin M, Carlsson G, Fadeel B, Dahl N and Palmblad J. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nature genetics. 2007; 39(1):86-92.
10. Deveraux QL and Reed JC. IAP family proteins-suppressors of apoptosis. Genes & development. 1999; 13(3):239-252.
11. Deveraux QL, Takahashi R, Salvesen GS and Reed JC. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 1997; 388(6639):300-304.
12. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T and Reed JC. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer research. 1998; 58(23):5315-5320.
13. LaCasse EC, Baird S, Korneluk RG and MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene. 1998; 17(25):3247-3259.
14. Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, Kitada S, Scudiero DA, Tudor G, Qui YH, Monks A, Andreeff M and Reed JC. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clinical cancer research: an official journal of the American Association for Cancer Research. 2000; 6(5): 1796-1803.
15. Li J, Feng Q, Kim JM, Schneiderman D, Liston P, Li M, Vanderhyden B, Faught W, Fung MF, Senterman M, Korneluk RG and Tsang BK. Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins. Endocrinology. 2001; 142(1):370-380.
16. Vucic D and Fairbrother WJ. The inhibitor of apoptosis proteins as therapeutic targets in cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2007; 13(20):5995-6000.
17. Hunter AM, LaCasse EC and Korneluk RG. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis: an international journal on programmed cell death. 2007; 12(9):1543-1568.
18. Eckelman BP and Salvesen GS. The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. The Journal of biological chemistry. 2006; 281(6):3254-3260.
19. Yang Y, Fang S, Jensen JP, Weissman AM and Ashwell JD. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science. 2000; 288(5467):874-877.
20. Vallabhapurapu S, Matsuzawa A, Zhang W, Tseng PH, Keats JJ, Wang H, Vignali DA, Bergsagel PL and Karin M. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nature immunology. 2008; 9(12):1364-1370.
21. Zarnegar BJ, Wang Y, Mahoney DJ, Dempsey PW, Cheung HH, He J, Shiba T, Yang X, Yeh WC, Mak TW, Korneluk RG and Cheng G. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nature immunology. 2008; 9(12):1371-1378.
22. Coope HJ, Atkinson PG, Huhse B, Belich M, Janzen J, Holman MJ, Klaus GG, Johnston LH and Ley SC. CD40 regulates the processing of NF-kappaB2 p100 to p52. The EMBO journal. 2002; 21(20):5375-5385.
23. Claudio E, Brown K, Park S, Wang H and Siebenlist U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nature immunology. 2002; 3(10):958-965.
24. Madge LA, Kluger MS, Orange JS and May MJ. Lymphotoxin-alpha 1 beta 2 and LIGHT induce classical and noncanonical NF-kappa B-dependent proinflammatory gene expression in vascular endothelial cells. Journal of immunology. 2008; 180(5):3467-3477.
25. Senftleben U, Cao Y, Xiao G, Greten FR, Krahn G, Bonizzi G, Chen Y, Hu Y, Fong A, Sun SC and Karin M. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science. 2001; 293(5534):1495-1499.
26. Xiao G, Harhaj EW and Sun SC. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Molecular cell. 2001; 7(2):401-409.
27. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ and Vaux DL. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell. 2000; 102(1):43-53.
28. Yang QH and Du C. Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells. The Journal of biological chemistry. 2004; 279(17):16963-16970.
29. Gyrd-Hansen M, Darding M, Miasari M, Santoro MM, Zender L, Xue W, Tenev T, da Fonseca PC, Zvelebil M, Bujnicki JM, Lowe S, Silke J and Meier P. IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis. Nature cell biology. 2008; 10(11):1309-1317.
30. Cossu F, Mastrangelo E, Milani M, Sorrentino G, Lecis D, Delia D, Manzoni L, Seneci P, Scolastico C and Bolognesi M. Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2. Biochemical and biophysical research communications. 2009; 378(2):162-167.
31. Feltham R, Bettjeman B, Budhidarmo R, Mace PD, Shirley S, Condon SM, Chunduru SK, McKinlay MA, Vaux DL, Silke J and Day CL. Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization. J Biol Chem. 2011; 286(19):17015-17028.
32. Dueber EC, Schoeffler AJ, Lingel A, Elliott JM, Fedorova AV, Giannetti AM, Zobel K, Maurer B, Varfolomeev E, Wu P, Wallweber HJ, Hymowitz SG, Deshayes K, Vucic D and Fairbrother WJ. Antagonists induce a conformational change in cIAP1 that promotes autoubiquitination. Science. 2011; 334(6054):376-380.
33. Kang YJ, Jang M, Park YK, Kang S, Bae KH, Cho S, Lee CK, Park BC, Chi SW and Park SG. Molecular interaction between HAX-1 and XIAP inhibits apoptosis. Biochemical and biophysical research communications. 2010; 393(4):794-799.
34. Huang H, Joazeiro CA, Bonfoco E, Kamada S, Leverson JD and Hunter T. The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. The Journal of biological chemistry. 2000; 275(35):26661-26664.
35. Vaux DL and Silke J. IAPs, RINGs and ubiquitylation. Nature reviews Molecular cell biology. 2005; 6(4):287-297.
36. Vaux DL and Silke J. IAPs--the ubiquitin connection. Cell death and differentiation. 2005; 12(9):1205-1207.
37. Szwarc M, Sarnowska E and Grzybowska EA. [HAX-1 protein: multifunctional factor involved in apoptosis, cell migration, endocytosis and mRNA transport]. Postepy biochemii. 2007; 53(3):218-227.
38. Grzybowska EA, Zayat V, Konopinski R, Trebinska A, Szwarc M, Sarnowska E, Macech E, Korczynski J, Knapp A and Siedlecki JA. HAX-1 is a nucleocytoplasmic shuttling protein with a possible role in mRNA processing. The FEBS journal. 2013; 280(1):256-272.
39. Silke J, Kratina T, Chu D, Ekert PG, Day CL, Pakusch M, Huang DC and Vaux DL. Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundance. Proc Natl Acad Sci U S A. 2005; 102(45):16182-16187.
40. Deshaies RJ and Joazeiro CA. RING domain E3 ubiquitin ligases. Annual review of biochemistry. 2009; 78:399-434.
41. Mace PD, Linke K, Feltham R, Schumacher FR, Smith CA, Vaux DL, Silke J and Day CL. Structures of the cIAP2 RING domain reveal conformational changes associated with ubiquitin-conjugating enzyme (E2) recruitment. The Journal of biological chemistry. 2008; 283(46): 31633-31640.
42. Ozkan E, Yu H and Deisenhofer J. Mechanistic insight into the allosteric activation of a ubiquitin-conjugating enzyme by RING-type ubiquitin ligases. Proc Natl Acad Sci U S A. 2005; 102(52):18890-18895.
43. Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, Garg P, Zobel K, Dynek JN, Elliott LO, Wallweber HJ, Flygare JA, Fairbrother WJ, Deshayes K, Dixit VM and Vucic D. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell. 2007; 131(4):669-681.
44. Yilmaz ZB, Weih DS, Sivakumar V and Weih F. RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF. The EMBO journal. 2003; 22(1):121-130.
45. Hofmann K, Bucher P and Tschopp J. The CARD domain: a new apoptotic signalling motif. Trends in biochemical sciences. 1997; 22(5):155-156.
46. Nakatani Y, Kleffmann T, Linke K, Condon SM, Hinds MG and Day CL. Regulation of ubiquitin transfer by XIAP, a dimeric RING E3 ligase. The Biochemical journal. 2013; 450(3):629-638.
47. Lopez J, John SW, Tenev T, Rautureau GJ, Hinds MG, Francalanci F, Wilson R, Broemer M, Santoro MM, Day CL and Meier P. CARD-mediated autoinhibition of cIAP1's E3 ligase activity suppresses cell proliferation and migration. Molecular cell. 2011; 42(5):569-583.
48. Koontz J and Kontrogianni-Konstantopoulos A. Competition through Dimerization between Antiapoptotic and Proapoptotic HS-1-associated Protein X-1 (Hax-1). The Journal of biological chemistry. 2014; 289(6):3468-3477.
49. Eckhardt I, Roesler S and Fulda S. Identification of DR5 as a critical, NF-kappaB-regulated mediator of Smac-induced apoptosis. Cell death & disease. 2013; 4:e936.
50. Conze DB, Albert L, Ferrick DA, Goeddel DV, Yeh WC, Mak T and Ashwell JD. Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Molecular and cellular biology. 2005; 25(8):3348-3356.
51. Darding M, Feltham R, Tenev T, Bianchi K, Benetatos C, Silke J and Meier P. Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2. Cell death and differentiation. 2011; 18(8):1376-1386.
52. Jitkaew S, Trebinska A, Grzybowska E, Carlsson G, Nordstrom A, Lehtio J, Frojmark AS, Dahl N and Fadeel B. N(alpha)-tosyl-L-phenylalanine chloromethyl ketone induces caspase-dependent apoptosis in transformed human B cell lines with transcriptional down-regulation of anti-apoptotic HS1-associated protein X-1. The Journal of biological chemistry. 2009; 284(41):27827-27837.
53. Peckl-Schmid D, Wolkerstorfer S, Konigsberger S, Achatz-Straussberger G, Feichtner S, Schwaiger E, Zaborsky N, Huemer M, Gratz IK, Schibli R, Lamers M, Crameri R, Moser K, Luger EO and Achatz G. HAX1 deficiency: impact on lymphopoiesis and B-cell development. European journal of immunology. 2010; 40(11):3161-3172.